Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Germline mutations in Chinese ovarian cancer with or without breast cancer.

Molecular genetics & genomic medicine - 1 Jul 2022

Kwong Ava, Ho Cecilia Yuen Sze, Shin Vivian Yvonne, Au Chun Hang, Luk Wing Pan, Fung Ling Hiu, Chan Tsun-Leung, Chan Karen Kar Loen, Ngan Hextan Yuen Sheung, Ma Edmond Shiu Kwan

Abstract excerpt

BACKGROUND: Ovarian and breast cancers are known to have significant genetic components. Considering the differences in the mutation spectrum across ethnicity, it is important to identify hereditary breast and ovarian cancer (HBOC) genes mutation in Chinese for clinical management. METHODS: Two cohorts of 451 patients with ovarian cancer only (OV) and 93 patients with both breast and ovarian (BROV) cancers were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fanconi Anemia Complementation Group N Protein

Share to Genetic Predisposition to Disease

Share to Germ-Line Mutation

Share to MutS Homolog 2 Protein

Share to Ovarian Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35608067
DOI: 10.1002/mgg3.1940
PMCID: PMC9266594

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Germline mutations in Chinese ovarian cancer with or without breast cancer.PMID 35608067Read ↗

BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.Semantic proximity Read ↗

Frequency of mutations in 21 hereditary breast and ovarian cancer susceptibility genes among high-risk Chinese individualsSemantic proximity Read ↗

Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort studySemantic proximity Read ↗

Inherited Mutations in Women With Ovarian Carcinoma.Semantic proximity Read ↗

Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.Semantic proximity Read ↗

Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing.Semantic proximity Read ↗

Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.Semantic proximity Read ↗

Multigene germline testing for epithelial ovarian cancer in China.Semantic proximity Read ↗

Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.Semantic proximity Read ↗

Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.Semantic proximity Read ↗

Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients from Yunnan Province in southwest China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.